Your browser doesn't support javascript.
loading
EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells.
Talukdar, Sarmistha; Emdad, Luni; Das, Swadesh K; Fisher, Paul B.
Afiliação
  • Talukdar S; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States.
  • Emdad L; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Massey Cancer Center, Virginia Commonwealth Unive
  • Das SK; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Massey Cancer Center, Virginia Commonwealth Unive
  • Fisher PB; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, United States; VCU Massey Cancer Center, Virginia Commonwealth Unive
Adv Cancer Res ; 147: 161-188, 2020.
Article em En | MEDLINE | ID: mdl-32593400

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos